Rifampicin-warfarin interaction leading to macroscopic hematuria: a case report and review of the literature

BACKGROUND: Rifampicin remains one of the first-line drugs used in tuberculosis therapy. This drug´s potential to induce the hepatic cytochrome P450 oxidative enzyme system increases the risk of drug-drug interactions. Thus, although the presence of comorbidities typically necessitates the use of mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Martins, Maria AP, Reis, Adriano MM, Sales, Mariana F, Nobre, Vandack, Ribeiro, Daniel D, Rocha, Manoel OC, Ribeiro, Antônio LP
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653703/
https://www.ncbi.nlm.nih.gov/pubmed/23641931
http://dx.doi.org/10.1186/2050-6511-14-27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653703/
https://www.ncbi.nlm.nih.gov/pubmed/23641931
http://dx.doi.org/10.1186/2050-6511-14-27

Ejemplares similares